Background: Timeliness is an important dimension of health care quality. It is unclear
whether timeliness improves clinical outcomes in patients with lung cancer. Methods: This …

Background With a 5% improvement in 5-year overall survival achieved with current
neoadjuvant or adjuvant chemotherapy, new treatments for resectable non-small cell lung …

Background: Patients frequently voice concerns regarding wait times for cancer treatment;
however, little is known about the length of wait times from diagnosis to surgery in the United …

Objectives This study aimed to determine if treatment delay after non-small cell lung cancer
(NSCLC) diagnosis impacts patient survival rate. Study design This study is a natural …

Timely care is an important dimension of health care quality, but the impact of delays in care
on lung cancer outcomes is unclear. Quantifying the impact of delays in cancer treatment on …

Introduction Lung cancer diagnostic and treatment delays have been described for several
patient populations. However, few studies have analyzed these intervals among patients …

Background Coronavirus disease 2019 (COVID-19) has overwhelmed hospital resources
worldwide, requiring widespread cancellation of non-emergency operations, including lung …

Introduction A subset of patients with potentially resectable clinical stage IIIA NSCLC are
managed with trimodality therapy. However, little data exist to guide the timing of surgery …

Background Timely care of lung cancer is presumed critical, yet clear evidence of stage
progression with delays in care is lacking. We investigated the reasons for delays in …

Background Timeliness is an important dimension of quality of care for patients with lung
cancer. Methods We reviewed the records of consecutive patients in whom non-small cell …